{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:28:57Z","timestamp":1790051337475,"version":"4.0.1"},"reference-count":41,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Severe ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) deficiency causes thrombotic thrombocytopenic purpura (TTP), which is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and the absence of oliguric or anuric renal failure. However, some patients with this constellation of findings do not have ADAMTS13 deficiency, and some patients with ADAMTS13 deficiency have renal failure or relatively normal blood counts. Consequently, many investigators and clinicians have incorporated severe ADAMTS13 deficiency into the case definition of TTP. This change has facilitated the timely initiation of treatment for patients with atypical clinical features who otherwise would not be recognized as having TTP. Conversely, excluding severe ADAMTS13 deficiency focuses attention on the diagnosis and treatment of other causes of thrombotic microangiopathy that require different treatment. The rapid return of ADAMTS13 data is important to make the best use of this information.<\/jats:p>","DOI":"10.1182\/asheducation-2015.1.631","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T15:23:25Z","timestamp":1473953005000},"page":"631-636","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":83,"title":["What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura"],"prefix":"10.1182","volume":"2015","author":[{"given":"J. Evan","family":"Sadler","sequence":"first","affiliation":[{"name":"Departments of Medicine and Biochemistry and"},{"name":"Molecular Biophysics, Washington University School of Medicine, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2019111704084360700_B1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","article-title":"Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura","volume":"112","author":"Sadler","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111704084360700_B2","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"2019111704084360700_B3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111704084360700_B4","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1537-2995.2011.03125.x","article-title":"Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency","volume":"51","author":"Terrell","year":"2011","journal-title":"Transfusion"},{"issue":"7","key":"2019111704084360700_B5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111704084360700_B6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019111704084360700_B7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MOP.0b013e32835e7888","article-title":"Thrombotic thrombocytopenic purpura in children","volume":"25","author":"Loirat","year":"2013","journal-title":"Curr Opin Pediatr"},{"issue":"8","key":"2019111704084360700_B8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2019111704084360700_B9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"2019111704084360700_B10","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"2019111704084360700_B11","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/CCM.0b013e31828a24a8","article-title":"Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome","volume":"41","author":"Braune","year":"2013","journal-title":"Crit Care Med"},{"issue":"7","key":"2019111704084360700_B12","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1212\/WNL.0000000000000120","article-title":"Clinical and radiologic features of encephalopathy during 2011 E coli O111 outbreak in Japan","volume":"82","author":"Takanashi","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"2019111704084360700_B13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jca.21216","article-title":"A case series of atypical presentations of thrombotic thrombocytopenic purpura","volume":"27","author":"Imanirad","year":"2012","journal-title":"J Clin Apher"},{"issue":"4","key":"2019111704084360700_B14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1160\/TH14-04-0359","article-title":"Neurological symptoms as the sole presentation of relapsed thrombotic thrombocytopenic purpura without microangiopathic haemolytic anaemia","volume":"112","author":"Htun","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"2019111704084360700_B15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ajh.23249","article-title":"Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke","volume":"88","author":"Idowu","year":"2013","journal-title":"Am J Hematol"},{"issue":"22","key":"2019111704084360700_B16","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1212\/WNL.0b013e318294b423","article-title":"Pearls and oy-sters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura","volume":"80","author":"Rojas","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"2019111704084360700_B17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/jca.20276","article-title":"Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura","volume":"26","author":"Sevy","year":"2011","journal-title":"J Clin Apher"},{"issue":"3","key":"2019111704084360700_B18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11739-012-0851-4","article-title":"Macrovascular thrombosis in critically ill patients with thrombotic micro-angiopathies","volume":"9","author":"Camous","year":"2014","journal-title":"Intern Emerg Med"},{"issue":"4","key":"2019111704084360700_B19","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1212\/WNL.50.4.1157","article-title":"Middle cerebral artery main stem thrombosis in two siblings with familial thrombotic thrombocytopenic purpura","volume":"50","author":"Kelly","year":"1998","journal-title":"Neurology"},{"issue":"5","key":"2019111704084360700_B20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2141.2003.04360.x","article-title":"Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura","volume":"121","author":"Yarranton","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111704084360700_B21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1076029613495309","article-title":"Experiences in a family with the Upshaw-Schulman syndrome over a 44-year period","volume":"20","author":"Bennett","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"2019111704084360700_B22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"issue":"8","key":"2019111704084360700_B23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","article-title":"Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity","volume":"46","author":"Kato","year":"2006","journal-title":"Transfusion"},{"issue":"6","key":"2019111704084360700_B24","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jth.12881","article-title":"Subcommittee on von Willebrand F. Establishment of the WHO 1st International Standard ADAMTS13, plasma (12\/252): communication from the SSC of the ISTH","volume":"13","author":"Hubbard","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111704084360700_B25","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1002\/ajh.23851","article-title":"Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura","volume":"90","author":"Raval","year":"2015","journal-title":"Am J Hematol"},{"issue":"4","key":"2019111704084360700_B26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2004-11-4490","article-title":"ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases","volume":"106","author":"Rieger","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111704084360700_B27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2011.051433","article-title":"Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura","volume":"97","author":"Froehlich-Zahnd","year":"2012","journal-title":"Haematologica"},{"issue":"8","key":"2019111704084360700_B28","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/jth.12319","article-title":"An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura","volume":"11","author":"Muia","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111704084360700_B29","doi-asserted-by":"crossref","first-page":"e1004558","DOI":"10.1371\/journal.ppat.1004558","article-title":"Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria","volume":"11","author":"Barber","year":"2015","journal-title":"PLoS Pathog"},{"issue":"1","key":"2019111704084360700_B30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1160\/TH09-04-0223","article-title":"Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13","volume":"103","author":"Lowenberg","year":"2010","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111704084360700_B31","doi-asserted-by":"crossref","first-page":"e78801","DOI":"10.1371\/journal.pone.0078801","article-title":"Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy","volume":"8","author":"Colombatti","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"2019111704084360700_B32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1538-7836.2007.02438.x","article-title":"Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies","volume":"5","author":"Meyer","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111704084360700_B33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/jth.12901","article-title":"Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease","volume":"13","author":"Lu","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111704084360700_B34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","article-title":"Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis","volume":"99","author":"Uemura","year":"2008","journal-title":"Thromb Haemost"},{"issue":"5","key":"2019111704084360700_B35","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1600-6143.2009.02621.x","article-title":"Development of a severe von Willebrand factor\/ADAMTS13 dysbalance during orthotopic liver transplantation","volume":"9","author":"Pereboom","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"2019111704084360700_B36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"issue":"10","key":"2019111704084360700_B37","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","article-title":"Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure","volume":"36","author":"Nguyen","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"2019111704084360700_B38","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1186\/cc13115","article-title":"The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation","volume":"17","author":"Peigne","year":"2013","journal-title":"Crit Care"},{"issue":"11","key":"2019111704084360700_B39","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/j.1538-7836.2007.02743.x","article-title":"ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock","volume":"5","author":"Kremer Hovinga","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"14","key":"2019111704084360700_B40","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2013-08-508093","article-title":"Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome","volume":"123","author":"Hyseni","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111704084360700_B41","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/trf.12762","article-title":"Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura","volume":"55","author":"Wu","year":"2015","journal-title":"Transfusion"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/631\/1249717\/bep00115000631.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2015\/1\/631\/1249717\/bep00115000631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T09:09:21Z","timestamp":1573981761000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2015\/1\/631\/20558\/Whats-new-in-the-diagnosis-and-pathophysiology-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,5]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12,5]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2015.1.631","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,5]]}}}